These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 33363143)
1. Resolvins: Potent Pain Inhibiting Lipid Mediators via Transient Receptor Potential Regulation. Roh J; Go EJ; Park JW; Kim YH; Park CK Front Cell Dev Biol; 2020; 8():584206. PubMed ID: 33363143 [TBL] [Abstract][Full Text] [Related]
2. Emerging roles of resolvins in the resolution of inflammation and pain. Ji RR; Xu ZZ; Strichartz G; Serhan CN Trends Neurosci; 2011 Nov; 34(11):599-609. PubMed ID: 21963090 [TBL] [Abstract][Full Text] [Related]
4. The roles of special proresolving mediators in pain relief. Zhang LY; Jia MR; Sun T Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307 [TBL] [Abstract][Full Text] [Related]
5. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. Park CK; Xu ZZ; Liu T; Lü N; Serhan CN; Ji RR J Neurosci; 2011 Dec; 31(50):18433-8. PubMed ID: 22171045 [TBL] [Abstract][Full Text] [Related]
6. Role of Resolvins in Inflammatory and Neuropathic Pain. Park J; Roh J; Pan J; Kim YH; Park CK; Jo YY Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895837 [TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 and D2 Inhibit Transient Receptor Potential Vanilloid 1 and Ankyrin 1 Ion Channel Activation on Sensory Neurons via Lipid Raft Modification. Payrits M; Horváth Á; Biró-Sütő T; Erostyák J; Makkai G; Sághy É; Pohóczky K; Kecskés A; Kecskés M; Szolcsányi J; Helyes Z; Szőke É Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708653 [TBL] [Abstract][Full Text] [Related]
8. Biological Roles of Resolvins and Related Substances in the Resolution of Pain. Lim JY; Park CK; Hwang SW Biomed Res Int; 2015; 2015():830930. PubMed ID: 26339646 [TBL] [Abstract][Full Text] [Related]
9. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch. Ji RR Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219 [TBL] [Abstract][Full Text] [Related]
10. Role of Specialized Pro-Resolving Mediators in Neuropathic Pain. Leuti A; Fava M; Pellegrini N; Maccarrone M Front Pharmacol; 2021; 12():717993. PubMed ID: 34456731 [TBL] [Abstract][Full Text] [Related]
11. Neuroimmune interactions in itch: Do chronic itch, chronic pain, and chronic cough share similar mechanisms? Ji RR Pulm Pharmacol Ther; 2015 Dec; 35():81-6. PubMed ID: 26351759 [TBL] [Abstract][Full Text] [Related]
12. Roles of Resolvins in Chronic Inflammatory Response. Liu C; Fan D; Lei Q; Lu A; He X Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499209 [TBL] [Abstract][Full Text] [Related]
13. Role of the immune system in neuropathic pain. Malcangio M Scand J Pain; 2019 Dec; 20(1):33-37. PubMed ID: 31730538 [TBL] [Abstract][Full Text] [Related]
15. Endogenous Inflammatory Mediators Produced by Injury Activate TRPV1 and TRPA1 Nociceptors to Induce Sexually Dimorphic Cold Pain That Is Dependent on TRPM8 and GFRα3. Yang C; Yamaki S; Jung T; Kim B; Huyhn R; McKemy DD J Neurosci; 2023 Apr; 43(15):2803-2814. PubMed ID: 36898840 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain. Ueda H Prog Lipid Res; 2021 Jan; 81():101079. PubMed ID: 33259854 [TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives. Tajbakhsh A; Yousefi F; Farahani N; Savardashtaki A; Reiner Z; Jamialahmadi T; Sahebkar A Curr Med Chem; 2023 Jul; ():. PubMed ID: 37497711 [TBL] [Abstract][Full Text] [Related]
18. Inflammation in pathogenesis of chronic pain: Foe and friend. Fang XX; Zhai MN; Zhu M; He C; Wang H; Wang J; Zhang ZJ Mol Pain; 2023; 19():17448069231178176. PubMed ID: 37220667 [TBL] [Abstract][Full Text] [Related]